Welcome to the working week. Hello, everyone, and nice to see you again. We hope the weekend was refreshing and fun. Now, though, the routine of meetings and deadlines is upon us. Of course, this calls for the mandatory cup of stimulation. So grab one yourself, or a water bottle if you prefer, and get ready. To help you along, we have assembled some interesting items. Drop us a line if you find something interesting yourself. Meanwhile, hope your day is productive...
Cephalon Loses Fentora Patent Ruling (Associated Press)
HIV Drug Success Also Means Development Withers (Bloomberg News)
Merck Faces Contamination Clean-Up After Plant Closure (Albany Herald)
Dendreon Chief Scientific Officer To Retire (Xconomy)
Number Of Lawsuits Challenging Brand-Name Patents Are Rising (Fortune)
Glaxo And Tolerx Diabetes Drug Fails Phase Three (Pharma Times)
Will FDA Fast Track Of KV Premature Birth Drug Backfire? (St. Louis Post-Dispatch)
Michigan Rx Spending Is 'Indefensible' Says Senator (Niles Daily Star)